Pharmacological strategies for treating misfolded rhodopsin-associated autosomal dominant retinitis pigmentosa
Authors:
Open Access
- 1 January 2022
- journal article
- editorial
- Published by Medknow in Neural Regeneration Research
- Vol. 17 (1) , 110-112
Abstract
Neural Regen Res, Official publication of Publishing House of Neural Regeneration Research China Association of Rehabilitation Medicine,ChinaKeywords
This publication has 15 references indexed in Scilit:
- A novel small molecule chaperone of rod opsin and its potential therapy for retinal degenerationNature Communications, 2018
- Increased proteasomal activity supports photoreceptor survival in inherited retinal degenerationNature Communications, 2018
- The molecular and cellular basis of rhodopsin retinitis pigmentosa reveals potential strategies for therapyProgress in Retinal and Eye Research, 2018
- Let There Be Light: Gene and Cell Therapy for BlindnessHuman Gene Therapy, 2016
- Restoration of visual function in P23H rhodopsin transgenic rats by gene delivery of BiP/Grp78Proceedings of the National Academy of Sciences, 2010
- Retinitis pigmentosaThe Lancet, 2006
- G Protein–Coupled Receptor RhodopsinAnnual Review of Biochemistry, 2006
- Retinal and Peripheral Nerve Toxicity Induced by the Administration of a Pan-Cyclin Dependent Kinase (cdk) Inhibitor in MiceToxicologic Pathology, 2006
- Neuroprotection by hypoxic preconditioning: HIF-1 and erythropoietin protect from retinal degenerationSeminars in Cell & Developmental Biology, 2005
- Ribozyme rescue of photoreceptor cells in a transgenic rat model of autosomal dominant retinitis pigmentosaNature Medicine, 1998